Symyx Technologies, Inc., a US-based provider of technologies for R&D, has announced that it has joined SAFE-BioPharma Association, a non-profit association that created and manages the SAFE-BioPharma digital identity and signature standard for the pharmaceutical and healthcare industries. The membership enables Symyx to implement the SAFE-BioPharma digital signature standard for records signing to safe-guard critical scientific data. The membership also enables Symyx to participate in SAFE-BioPharma working groups to further secure the electronic laboratory environment.
Symyx customers can utilise SAFE-BioPharma digital signature within Symyx Notebook, an enterprise electronic lab notebook (ELN). Symyx Notebook supports multiple scientific disciplines including biology, chemistry, formulations development, and analytical laboratories where protecting intellectual property, avoiding patent interference, and satisfying regulatory agency submissions are critical activities. It enables scientists to plan, execute and analyse experiments across the spectrum of research, development and analytical QC labs while providing data and document workflow transparency to life sciences and chemicals businesses.
Symyx Notebook experimental entries provide key documentation for the intellectual properties of Symyx’s pharmaceutical and biotechnology customers, establishing the date of record for invention which is vital to patent claims and patent defense litigation. The Symyx Notebook platform also enables scientists to connect with their existing laboratory instrumentation and software tools to gain compliance protection without redeveloping operational business practices.
Search for more such document management related products/services in K-Store
Discuss this NEWS
